Delivery Order SPE2D021DA002-SPE2D326F3176
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $7,090.20 for ENGERIX-B 20 MCG/ML vaccine syringes. The award, issued on August 6, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract is funded through the Defense Logistics Agency's Medical Supply Chain program, which procures pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,181.70 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. The contract calls for the delivery of ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine, with an ultimate completion date of August 14, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,969.50 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025, with an ultimate completion date of September 15, 2025. The delivery order covers ENGERIX-B 20 micrograms per milliliter in syringe format, a hepatitis B vaccine commonly administered to military personnel and federal healthcare...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,969.50 on May 30, 2025, for ENGERIX-B 20 MCG/ML syringes. This firm fixed-price delivery order, which is expected to be completed by June 4, 2025, was issued without a set-aside designation. The award is funded through the Medical Supply Chain division of the Defense Logistics Agency, reflecting the Department of Defense's ongoing need for...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order valued at $1,401.93 by the Defense Logistics Agency on October 27, 2025. This delivery order, issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, represents a firm fixed-price award with an ultimate completion date of October 28, 2025. The award carries no set-aside designation, demonstrating the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,026.96 by the Defense Logistics Agency on November 24, 2025. This firm fixed-price delivery order represents one of numerous purchases issued to the contractor under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion Department of Defense acquisition strategy designed to consolidate...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,878.00 by the Defense Logistics Agency's Medical Supply Chain on August 5, 2025, for the supply of ENGERIX-B 20 MCG/ML syringes. This firm fixed-price delivery order, which carries an ultimate completion date of August 8, 2025, represents a discrete procurement action under the company's existing Indefinite Delivery Contract with DLA....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,578.00 by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccines. The award carries no set-aside designation and has an ultimate completion date of July 30, 2025, with performance taking place at the vendor's Park Ridge, Illinois location. This delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,980.48 by the Defense Logistics Agency on November 13, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, issued under the broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The company will provide pharmaceutical products and medical consumables to support...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $110,219.22 by the Defense Logistics Agency on November 10, 2025, with an ultimate completion date of November 12, 2025. This delivery order, issued without set-aside designation, is executed under the company's single-award Indefinite Delivery Contract (SPE2DR) under the Defense Logistics Agency's Pharmaceutical Prime Vendor...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D326F3176Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,908.50 for ENGERIX-B 20 MCG/ML vaccine on January 5, 2026. This delivery order was issued without a set-aside designation under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which represents a $30.3 billion acquisition strategy designed to supply pharmaceutical products to Department of Defense military healthcare facilities worldwide. The order is expected to be completed by January 6, 2026, with performance at the contractor's location in Park Ridge, Illinois. This delivery order is issued pursuant to DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) under the PPV-G GEN V program, awarded on November 13, 2025, with a ceiling value of $499,999,999 and a completion date of December 31, 2036. The underlying IDC authorizes the Defense Logistics Agency to issue delivery orders for comprehensive pharmaceutical products including branded and generic prescription medications, biologics, vaccines, and medical consumables to support the global medical supply needs of the military healthcare system. As a critical regional prime vendor contractor, DMS Pharmaceutical Group has demonstrated substantial performance capability through numerous prior delivery orders, positioning it as a key supplier within the federal pharmaceutical supply chain for DoD operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 1/4/26 |